Authors: Albanese, A Bonuccelli, U Brefel, C Chaudhuri, KR Colosimo, C Eichhorn, T Melamed, E Pollak, P Van Laar, T Zappia, M

Citation: A. Albanese et al., Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease, MOVEMENT D, 16(2), 2001, pp. 197-201

Authors: Arnulf, I Vidailhet, M Bonnet, AM Descombes, S Jaillon, C Agid, Y Brefel, C Rascol, O Xie, J Pollak, P Cattelin, F

Citation: I. Arnulf et al., Blockade of cholecystokinin-A receptors has no effect on dyskinesias in Parkinson's disease, J NE NE PSY, 70(6), 2001, pp. 812-813

Authors: Masson, GS Mestre, DR Martineau, F Soubrouillard, C Brefel, C Rascol, O Blin, O

Citation: Gs. Masson et al., Lorazepam-induced modifications of saccadic and smooth-pursuit eye movements in humans: attentional and motor factors, BEH BRA RES, 108(2), 2000, pp. 169-180

Authors: Agid, Y Destee, A Durif, F Montastruc, JL Pedarriosse, AM Deptula, D Hoffman-La Roche, F Pollak, P Bonnet, AM Allain, H le Cavorzin, P Barroche, G Blin, O Cesaro, P Chazot, G Broussolle, E Leduc, V Debilly, B Feve, JR Geraud, G Fabre, N Gu, C Gil, R Henry, P Tison, F Ansquer, O Brefel, C Payen, I Said, G Plante, V Touchon, J Cesari, JB Camu, W Bennys, K Viallet, F Warter, JM Tranchant, C Ziegler, M

Citation: Y. Agid et al., Efficacy and tolerability of tolcapone compared with bromocriptine in levodopa-treated parkinsonian patients, MOVEMENT D, 14(1), 1999, pp. 38-44

Authors: Bezard, E Brefel, C Tison, F Peyro-Saint-Paul, H Ladure, P Rascol, O Gross, CE

Citation: E. Bezard et al., Effect of the alpha 2 adrenoreceptor antagonist, idazoxan, on motor disabilities in MPTP-treated monkey, PROG NEUR-P, 23(7), 1999, pp. 1237-1246

Authors: Senard, JM Brefel, C Carel, C Tran, MA Montastruc, JL

Citation: Jm. Senard et al., Water drinking and the heart, LANCET, 353(9168), 1999, pp. 1971-1971